Kera Capital Partners, Inc. Charles River Laboratories International, Inc. Transaction History
Kera Capital Partners, Inc.
- $483 Million
- Q2 2025
A detailed history of Kera Capital Partners, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Kera Capital Partners, Inc. holds 1,850 shares of CRL stock, worth $292,374. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,850
Previous 1,900
2.63%
Holding current value
$292,374
Previous $286 Million
99.9%
% of portfolio
0.06%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding CRL
# of Institutions
642Shares Held
54.7MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$965 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$804 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$677 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$378 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$308 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.04B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...